Bacterial Conjunctivitis
Bacterial conjunctivitis
7
Effectiveness, tolerability and safety of azithromycin 1% in DuraSite<sup>®</sup> for acute bacterial conjunctivitis
8
Clinical use of gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis
8
A 3-day regimen with azithromycin 1.5% eyedrops for the treatment of purulent bacterial conjunctivitis in children: efficacy on clinical signs and impact on the burden of illness
8
Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: microbiological eradication outcomes
9
A chronological study of the bacterial pathogen changes in acute neonatal bacterial conjunctivitis in southern China
6
Clinical outcomes with besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis due to potentially consequential pathogens
11
Estimate of the direct and indirect annual cost of bacterial conjunctivitis in the United States
11
Besifloxacin: a novel anti-infective for the treatment of bacterial conjunctivitis
11
Kinetics of kill of bacterial conjunctivitis isolates with moxifloxacin, a fluoroquinolone, compared with the aminoglycosides tobramycin and gentamicin
5
Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: etiology of bacterial conjunctivitis and antibacterial susceptibility profile
11
“IN-VITRO ANTIBACTERIAL ADHERENCE ACTIVITY STUDY OF ANTIBIOTICS WHICH ARE USED IN THE TREATMENT OF BACTERIAL CONJUNCTIVITIS” by Shoujaa Ahmad, Al-Ammori Mustafa, Syria.
6
Original Article Spectrum of Bacterial Conjunctivitis and Their Drug Sensitivity (Efficacy) Pattern, in the Patients Attending in Tertiary Care Hospital at Muzaffarpur, Bihar
5
Besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis patients with <em>Pseudomonas aeruginosa</em> infections
10
“In Situ Gel for Treatment of Bacterial Conjunctivitis” by Ankita Kapoor, G.D Gupta, India.
7
Conjunctivitis in dupilumab clinical trials
16
Α molecular epidemiological analysis of adenoviruses from excess conjunctivitis cases
7
<p>Direct and Indirect Costs of Infectious Conjunctivitis in a Commercially Insured Population in the United States</p>
11
Prevelance of virulent Gram positive bacilli causing eye infection
15
<p>A Review of the Differential Diagnosis of Acute Infectious Conjunctivitis: Implications for Treatment and Management</p>
9